Foto del docente

Irene Faenza

Full Professor

Department of Biomedical and Neuromotor Sciences

Academic discipline: BIO/16 Human Anatomy

Director of Second Cycle Degree in Medical Biotechnology


vai alle Pubblicazioni

Publications prior to 2004




67 : Bavelloni A, Poli A, Fiume R,  Blalock W, Matteucci A, Ramazzotti G, McCubrey JA, Cocco L, Faenza I. PLC-beta 1 regulates the expression of miR-210 during mithramycin-mediated erythroid differentiation in K562 cells. Oncotarget 2014. Accepted and in press . (IF: 6,63)


66 : Bavelloni A, Piazzi M, Faenza I, Raffini M, D'Angelo A, Cattini L, Cocco L, Blalock WL. Prohibitin 2 represents a novel nuclear AKT substrate during all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. FASEB J. 2014 Feb 12.  PubMed PMID: 24522204. (IF: 5,704)


65 : Blalock WL, Piazzi M, Bavelloni A, Raffini M, Faenza I, D'Angelo A, Cocco L. Identification of the PKR Nuclear Interactome Reveals Roles in Ribosome Biogenesis, mRNA Processing and Cell Division. J Cell Physiol. 2013 Dec 18. doi: 10.1002/jcp.24529. PubMed PMID: 24347309. (IF:4,218)


64 : Follo MY, Faenza I, Piazzi M, Blalock WL, Manzoli L, McCubrey JA, Cocco L. Nuclear PI-PLC β 1: an appraisal on targets and pathology. Adv Biol Regul. 2014 Jan;54:2-11. doi: 10.1016/j.jbior.2013.11.003. Epub 2013 Nov 20. PubMed PMID: 24296032.


63 : Faenza I, Fiume R, Piazzi M, Colantoni A, Cocco L. Nuclear inositide specific  phospholipase C signalling - interactions and activity. FEBS J. 2013 Dec;280(24):6311-21. doi: 10.1111/febs.12450. Epub 2013 Aug 20. Review. PubMed  PMID: 23890371. (IF:4,25)


62 : Piazzi M, Blalock WL, Bavelloni A, Faenza I, D'Angelo A, Maraldi NM, Cocco L.  Phosphoinositide-specific phospholipase C β 1b (PI-PLC β 1b) interactome: affinity purification-mass spectrometry analysis of PI PLC β 1b with nuclear protein. Mol Cell Proteomics. 2013 Aug;12(8):2220-35. doi:10.1074/mcp.M113.029686. Epub 2013  May 9. PubMed PMID: 23665500; PubMed Central PMCID: PMC3734581. (IF: 7,398)


61 : Poli A, Faenza I, Chiarini F, Matteucci A, McCubrey JA, Cocco L. K562 cell proliferation is modulated by PLC β 1 through a PKC α -mediated pathway. Cell Cycle. 2013 Jun 1;12(11):1713-21. doi: 10.4161/cc.24806. Epub 2013 May 6. PubMed PMID: 23656785; PubMed Central PMCID: PMC3713130. (IF: 5.24)


60 : Follo MY, Marmiroli S, Faenza I, Fiume R, Ramazzotti G, Martelli AM, Gobbi P, McCubrey JA, Finelli C, Manzoli FA, Cocco L. Nuclear phospholipase C β 1 signaling, epigenetics and treatments in MDS. Adv Biol Regul. 2013 Jan;53(1):2-7.doi: 10.1016/j.jbior.2012.09.009. Epub 2012 Sep 21. Review. PubMed PMID:23058275.


59 : Faenza I, Blalock W, Bavelloni A, Schoser B, Fiume R, Pacella S, Piazzi M, D'Angelo A, Cocco L. A role for PLC β 1 in myotonic dystrophies type 1 and 2. FASEB J. 2012 Jul;26(7):3042-8. doi: 10.1096/fj.11-200337. Epub 2012 Mar 29. PubMedPMID: 22459146.(IF: 5,704)


58 : Fiume R, Keune WJ, Faenza I, Bultsma Y, Ramazzotti G, Jones DR, Martelli AM, Somner L, Follo MY, Divecha N, Cocco L. Nuclear phosphoinositides: location,regulation and function. Subcell Biochem. 2012;59:335-61. doi: 10.1007/978-94-007-3015-1_11. PubMed PMID: 22374096.


57 : Follo MY, Mongiorgi S, Finelli C, Piazzi M, Faenza I, Ramazzotti G, Santi P,  McCubrey JA, Martelli AM, Cocco L. Nuclear PI-PLC β 1 and myelodysplastic syndromes: genetics and epigenetics. Curr Pharm Des. 2012;18(13):1751-4. Review. PubMed PMID: 22352752. (IF: 3,311)


56 : Ramazzotti G, Faenza I, Follo MY, Fiume R, Piazzi M, Giardino R, Fini M, Cocco L. Nuclear phospholipase C in biological control and cancer. Crit RevEukaryot Gene Expr. 2011;21(3):291-301. Review. PubMed PMID: 22111715. (IF: 2,07)


55 : Follo MY, Faenza I, Fiume R, Ramazzotti G, McCubrey JA, Martelli AM, Manzoli  FA, Cocco L. Revisiting nuclear phospholipase C signalling in MDS. Adv Biol Regul. 2012 Jan;52(1):2-6. Review. PubMed PMID: 21982979.


54 : Fiume R, Ramazzotti G, Faenza I, Piazzi M, Bavelloni A, Billi AM, Cocco L. Nuclear PLCs affect insulin secretion by targeting PPAR γ in pancreatic β cells. FASEB J. 2012 Jan;26(1):203-10. doi: 10.1096/fj.11-186510. Epub 2011 Oct 5.PubMed PMID: 21974932. (IF: 5,704)


53 : Blalock WL, Bavelloni A, Piazzi M, Tagliavini F, Faenza I, Martelli AM, Follo MY, Cocco L. Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress. Leukemia. 2011 Feb;25(2):236-45. doi: 10.1038/leu.2010.264. Epub 2010 Nov 12. PubMed PMID: 21072047.(IF: 10,64)


52 : Cocco L, Follo MY, Faenza I, Fiume R, Ramazzotti G, Weber G, Martelli AM, Manzoli FA. Physiology and pathology of nuclear phospholipase C β 1. Adv Enzyme Regul. 2011;51(1):2-12. doi: 10.1016/j.advenzreg.2010.09.015. Epub 2010 Oct 28. Review. PubMed PMID: 21035488.


51 : Piazzi M, Bavelloni A, Faenza I, Blalock W, Urbani A, D'Aguanno S, Fiume R, Ramazzotti G, Maraldi NM, Cocco L. eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser ⁵³ is a novel substrate for protein kinase C β I. Mol Cell Proteomics. 2010 Dec;9(12):2719-28. doi: 10.1074/mcp.M110.003152.  Epub 2010 Oct 5. PubMed PMID: 20923971; PubMed Central PMCID: PMC3101858. (IF: 7,398)


50 : Ramazzotti G*, Faenza I*, Fiume R, Matteucci A, Piazzi M, Follo MY, Cocco L. The physiology and pathology of inositide signaling in the nucleus. J Cell Physiol. 2011 Jan;226(1):14-20. doi: 10.1002/jcp.22334. Review. PubMed PMID:20658523. (IF:4,218) *contributed equally to this work


49 : Fiume R, Teti G, Faenza I, Cocco L. Phosphoinositide-specific phospholipase C beta1 signal transduction in the nucleus. Methods Mol Biol. 2010;645:143-64. doi:10.1007/978-1-60327-175-2_10. PubMed PMID: 20645187.


48 : Blalock WL, Bavelloni A, Piazzi M, Faenza I, Cocco L. A role for PKR in hematologic malignancies. J Cell Physiol. 2010 Jun;223(3):572-91. doi: 10.1002/jcp.22092. PubMed PMID: 20232306. (IF:4,218)


47 : Follo MY, Mongiorgi S, Finelli C, Clissa C, Ramazzotti G, Fiume R, Faenza I, Manzoli L, Martelli AM, Cocco L. Nuclear inositide signaling in myelodysplastic syndromes. J Cell Biochem. 2010 Apr 15;109(6):1065-71. doi: 10.1002/jcb.22483. Review. PubMed PMID: 20058233.(IF: 3,062)


46 : Bertagnolo V, Grassilli S, D'Aguanno S, Brugnoli F, Bavelloni A, Faenza I,Nika E, Urbani A, Cocco L, Capitani S. Mass spectrometry-based identification of  Y745 of Vav1 as a tyrosine residue crucial in maturation of acute promyelocytic leukemia-derived cells. J Proteome Res. 2010 Feb 5;9(2):752-60. doi:10.1021/pr900581y. PubMed PMID: 20028078. (IF: 5,506)


45 : Gaboardi GC, Ramazzotti G, Bavelloni A, Piazzi M, Fiume R, Billi AM,Matteucci A, Faenza I, Cocco L. A role for PKCepsilon during C2C12 myogenic differentiation. Cell Signal. 2010 Apr;22(4):629-35. doi:10.1016/j.cellsig.2009.11.017. Epub 2009 Nov 29. PubMed PMID: 19954762.(IF: 4,060)


44 : Cocco L, Follo MY, Faenza I, Billi AM, Ramazzotti G, Martelli AM, Manzoli L,  Weber G. Inositide signaling in the nucleus: from physiology to pathology. Adv Enzyme Regul. 2010;50(1):2-11. doi: 10.1016/j.advenzreg.2009.10.007. Epub 2009Nov 4. Review. PubMed PMID: 19895834.


43 : O'Carroll SJ, Mitchell MD, Faenza I, Cocco L, Gilmour RS. Nuclear PLCbeta1 is required for 3T3-L1 adipocyte differentiation and regulates expression of the cyclin D3-cdk4 complex. Cell Signal. 2009 Jun;21(6):926-35. PubMed PMID:19385066. (IF: 4,060)


42 : Cocco L, Faenza I, Follo MY, Billi AM, Ramazzotti G, Papa V, Martelli AM, Manzoli L. Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology. Adv Enzyme Regul. 2009;49(1):2-10. doi: 10.1016/j.advenzreg.2008.12.001. Epub 2008 Dec 31. Review. PubMed PMID: 19159640.


41 : Fiume R, Ramazzotti G, Teti G, Chiarini F, Faenza I, Mazzotti G, Billi AM, Cocco L. Involvement of nuclear PLCbeta1 in lamin B1 phosphorylation and G2/M cell cycle progression. FASEB J. 2009 Mar;23(3):957-66. doi:10.1096/fj.08-121244. Epub 2008 Nov 21. PubMed PMID: 19028838. . (IF: 5,704)


40 : Ramazzotti G, Faenza I, Gaboardi GC, Piazzi M, Bavelloni A, Fiume R, Manzoli  L, Martelli AM, Cocco L. Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. Cell Signal. 2008 Nov;20(11):2013-21. doi: 10.1016/j.cellsig.2008.07.009. Epub 2008 Jul 20. PubMed PMID: 18694821. (due primi nomi) (IF: 4,060)


39 : Cocco L, Faenza I, Follo MY, Ramazzotti G, Gaboardi GC, Billi AM, Martelli AM, Manzoli L. Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes. Adv Enzyme Regul. 2008;48:2-9. doi:10.1016/j.advenzreg.2007.11.013. Epub 2008 Mar 17. Review. PubMed PMID: 18280812.


38: Faenza I , Bregoli L, Ramazzotti G, Gaboardi G, Follo MY, Mongiorgi S, Billi AM, Manzoli L, Martelli AM, Cocco L. Nuclear phospholipase C beta1 and cellular differentiation. Front Biosci. 2008 Jan 1;13:2452-63. Review. PubMed PMID:17981726.(IF:3,063)


37 : Cocco L, Follo MY, Faenza I, Bavelloni A, Billi AM, Martelli AM, Manzoli L. Nuclear inositide signaling: an appraisal of phospholipase C beta 1 behavior in myelodysplastic and leukemia cells. Adv Enzyme Regul. 2007;47:2-9. Epub 2007 Mar 1. Review. PubMed PMID: 17335878.


36 : Faenza I, Ramazzotti G, Bavelloni A, Fiume R, Gaboardi GC, Follo MY, Gilmour  RS, Martelli AM, Ravid K, Cocco L. Inositide-dependent phospholipase C signaling  mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter. Endocrinology. 2007 Mar;148(3):1108-17. Epub 2006 Nov 22. PubMed PMID: 17122077. (IF: 4,833)


35 : Bavelloni A, Faenza I, Cioffi G, Piazzi M, Parisi D, Matic I, Maraldi NM, Cocco L. Proteomic-based analysis of nuclear signaling: PLCbeta1 affects the expression of the splicing factor SRp20 in Friend erythroleukemia cells. Proteomics. 2006 Nov;6(21):5725-34. PubMed PMID: 17022104. (IF: 4,132)


34 : Evangelisti C, Riccio M, Faenza I, Zini N, Hozumi Y, Goto K, Cocco L,Martelli AM. Subnuclear localization and differentiation-dependent increased expression of DGK-zeta in C2C12 mouse myoblasts. J Cell Physiol. 2006 Nov;209(2):370-8. PubMed PMID: 16897754. (IF:4,218)


33 : Cocco L, Martelli AM, Fiume R, Faenza I, Billi AM, Manzoli FA. Signal transduction within the nucleus: revisiting phosphoinositide inositide-specific phospholipase Cbeta1. Adv Enzyme Regul. 2006;46:2-11. Epub 2006 Jul 18. Review. PubMed PMID: 16846636.


32 : Follo MY, Bosi C, Finelli C, Fiume R, Faenza I, Ramazzotti G, Gaboardi GC, Manzoli L, Cocco L. Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. Int J Mol Med. 2006 Aug;18(2):267-71. PubMed PMID: 16820933. (IF: 1.957)


31 : Cocco L, Faenza I, Fiume R, Maria Billi A, Gilmour RS, Manzoli FA. Phosphoinositide-specific phospholipase C (PI-PLC) beta1 and nuclear lipid-dependent signaling. Biochim Biophys Acta. 2006 May-Jun;1761(5-6):509-21.Epub 2006 Mar 29. Review. PubMed PMID: 16624616. (IF: 3,848)


30 : Martelli AM, Faenza I, Billi AM, Manzoli L, Evangelisti C, Falà F, Cocco L. Intranuclear 3'-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis? Cell Signal. 2006 Aug;18(8):1101-7. Epub 2006 Mar 3. Review. PubMed PMID: 16516442. . (IF: 4,060)

29 : Faenza I, Billi AM, Follo MY, Fiume R, Martelli AM, Cocco L, Manzoli L. Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation. Anticancer Res. 2005 May-Jun;25(3B):2039-41. Review. PubMed PMID: 16158942.(IF: 1,725)


28 : Martelli AM, Fiume R, Faenza I, Tabellini G, Evangelista C, Bortul R, Follo MY, Falà F, Cocco L. Nuclear phosphoinositide specific phospholipase C(PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transduction. Histol Histopathol. 2005 Oct;20(4):1251-60. Review. PubMed PMID:16136505.(IF: 2,28)


27 : Manzoli L, Martelli AM, Billi AM, Faenza I, Fiume R, Cocco L. Nuclear phospholipase C: involvement in signal transduction. Prog Lipid Res. 2005 Jul;44(4):185-206. Epub 2005 Apr 26. Review. PubMed PMID: 15896848. (IF: 11,237)


26 : Fiume R, Faenza I, Matteucci A, Astolfi A, Vitale M, Martelli AM, Cocco L. Nuclear phospholipase C beta1 (PLCbeta1) affects CD24 expression in murine erythroleukemia cells. J Biol Chem. 2005 Jun24;280(25):24221-6. Epub 2005 Apr 22. PubMed PMID: 15849202.(IF: 4,651)


25 : Faenza I, Bavelloni A, Fiume R, Santi P, Martelli AM, Maria Billi A, Lo Vasco VR, Manzoli L, Cocco L. Expression of phospholipase C beta family isoenzymes in C2C12 myoblasts during terminal differentiation. J Cell Physiol. 2004 Aug;200(2):291-6. PubMed PMID: 15174099. (IF:4,218)


24 : Martelli AM, Falà F, Faenza I, Billi AM, Cappellini A, Manzoli L, Cocco L. Metabolism and signaling activities of nuclear lipids. Cell Mol Life Sci. 2004 May;61(10):1143-56. Review. PubMed PMID: 15141300.(IF: 5.615)


23 : Merlo Pich M, Raule N, Catani L, Fagioli ME, Faenza I, Cocco L, Lenaz G. Increased transcription of mitochondrial genes for Complex I in human platelets during ageing. FEBS Lett. 2004 Jan 30;558(1-3):19-22. PubMed PMID: 14759509. (IF:4,25)


22 : Martelli AM, Faenza I, Billi AM, Falà F, Cocco L, Manzoli L. Nuclear protein kinase C isoforms: key players in multiple cell functions? Histol Histopathol.2003 Oct;18(4):1301-12. Review. PubMed PMID: 12973696.(IF: 2.281)


21 : Faenza I, Bavelloni A, Fiume R, Lattanzi G, Maraldi NM, Gilmour RS, Martelli  AM, Suh PG, Billi AM, Cocco L. Up-regulation of nuclear PLCbeta1 in myogenic differentiation. J Cell Physiol. 2003 Jun;195(3):446-52. PubMed PMID: 12704654. (IF:4,218)


20 : Martelli AM, Manzoli L, Faenza I, Bortul R, Billi A, Cocco L. Nuclear inositol lipid signaling and its potential involvement in malignant transformation. Biochim Biophys Acta. 2002 Oct 2;1603(1):11-7. Review. PubMed PMID: 12242107. (I.F.: 10,11)

19 : Martelli AM, Bortul R, Tabellini G, Faenza I, Cappellini A, Bareggi R, Manzoli L, Cocco L. Molecular characterization of protein kinase C-alpha binding to lamin A. J Cell Biochem. 2002;86(2):320-30. PubMed PMID: 12112001. (I.F.: 3,06)


18 : Faenza I, Matteucci A, Bavelloni A, Marmiroli S, Martelli AM, Gilmour RS, Suh PG, Manzoli L, Cocco L. Nuclear PLCbeta(1) acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells. Biochim Biophys Acta. 2002 May 8;1589(3):305-10. PubMed PMID: 12031797. (I.F.: 4,94)


17 : Ponti C, Falconi M, Billi AM, Faenza I, Castorina S, Caimi L, Cacchioli A, Cocco L, Vitale M. IL-12 and IL-15 induce activation of nuclear PLCbeta in human natural killer cells. Int J Oncol. 2002 Jan;20(1):149-53. PubMed PMID: 11743656. (I.F.: 2,65)


16 : Martelli AM, Billi AM, Manzoli L, Faenza I, Aluigi M, Falconi M, De Pol A, Gilmour RS, Cocco L. Insulin selectively stimulates nuclear phosphoinositide-specific phospholipase C (PI-PLC) beta1 activity through amitogen-activated protein (MAP) kinase-dependent serine phosphorylation. FEBS Lett. 2000 Dec 15;486(3):230-6. PubMed PMID: 11119709. (IF:4,25)


15 : Faenza I, Matteucci A, Manzoli L, Billi AM, Aluigi M, Peruzzi D, Vitale M,Castorina S, Suh PG, Cocco L. A role for nuclear phospholipase Cbeta 1 in cell cycle control. J Biol Chem. 2000 Sep 29;275(39):30520-4. PubMed PMID: 10913438. (I.F.: 4,65)


14 : Peruzzi D, Calabrese G, Faenza I, Manzoli L, Matteucci A, Gianfrancesco F,Billi AM, Stuppia L, Palka G, Cocco L. Identification and chromosomal localisation by fluorescence in situ hybridisation of human gene ofphosphoinositide-specific phospholipase C beta(1). Biochim Biophys Acta. 2000 Apr 12;1484(2-3):175-82. PubMed PMID: 10760467. (I.F.: 4,94)


13 : Bavelloni A, Faenza I, Aluigi M, Ferri A, Toker A, Maraldi NM, Marmiroli S. Inhibition of phosphoinositide 3-kinase impairs pre-commitment cell cycle traverse and prevents differentiation in erythroleukaemia cells. Cell Death Differ. 2000 Jan;7(1):112-7. PubMed PMID: 10713726. (I.F.: 8,37)


12 : Manzoli L, Billi AM, Faenza I, Matteucci A, Martelli AM, Peruzzi D, Falconi M, Rhee SG, Gilmour RS, Cocco L. Nuclear phospholipase C: a novel aspect of phosphoinositide signalling. Anticancer Res. 1999 Sep-Oct;19(5A):3753-6. Review.  PubMed PMID: 10625953. (I.F. : 1,7)


11 : Cocco L, Rubbini S, Manzoli L, Billi AM, Faenza I, Peruzzi D, Matteucci A, Artico M, Gilmour RS, Rhee SG. Inositides in the nucleus: presence and characterisation of the isozymes of phospholipase beta family in NIH 3T3 cells. Biochim Biophys Acta. 1999 May 18;1438(2):295-9. PubMed PMID: 10320812. (I.F. 4,94)


10 : Bavelloni A, Santi S, Sirri A, Riccio M, Faenza I, Zini N, Cecchi S, Ferri A, Auron P, Maraldi NM, Marmiroli S. Phosphatidylinositol 3-kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma Saos-2 cells. J Cell Sci. 1999 Mar;112 ( Pt5):631-40. PubMed PMID: 9973598. (IF: 5.877)


9 : Matteucci A, Faenza I, Gilmour RS, Manzoli L, Billi AM, Peruzzi D, Bavelloni A, Rhee SG, Cocco L. Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells. Cancer Res. 1998 Nov 15;58(22):5057-60.PubMed PMID: 9823310. (IF: 8,650)


8 : Marmiroli S, Bavelloni A, Faenza I, Sirri A, Ognibene A, Cenni V, Tsukada J, Koyama Y, Ruzzene M, Ferri A, Auron PE, Toker A, Maraldi NM. Phosphatidylinositol3-kinase is recruited to a specific site in the activated IL-1 receptor I. FEBS Lett. 1998 Oct 30;438(1-2):49-54. PubMed PMID: 9821957. (IF:4,25)


7 : Billi AM, Matteucci A, Faenza I, Manzoli L, Rubbini S, Gilmour RS, Rhee SG, Cocco L. Control of expression of PLCbeta1 by LAC repressor system: relationship between nuclear PLCbeta1 overexpression and growth factor stimulation. Biochem Biophys Res Commun. 1997 Dec 8;241(1):122-6. PubMed PMID: 9405244. (IF: 2.406)


6 : Flamigni F, Faenza I, Marmiroli S, Stanic' I, Giaccari A, Muscari C, Stefanelli C, Rossoni C. Inhibition of the expression of ornithine decarboxylase and c-Myc by cell-permeant ceramide in difluoromethylornithine-resistant leukaemia cells. Biochem J. 1997 Jun 15;324 ( Pt 3):783-9. PubMed PMID: 9210401; PubMed Central PMCID: PMC1218493. (IF: 4.654)


5 : Manzoli L, Billi AM, Rubbini S, Bavelloni A, Faenza I, Gilmour RS, Rhee SG, Cocco L. Essential role for nuclear phospholipase C beta1 in insulin-like growth factor I-induced mitogenesis. Cancer Res. 1997 Jun 1;57(11):2137-9. PubMed PMID: 9187110. (IF: 8,650)


4 : Zini N, Sabatelli P, Faenza I, Ognibene A, Maraldi NM. Interleukin-1 alpha induces variations of the intranuclear amount of phosphatidylinositol 4,5-bisphosphate and phospholipase C beta 1 in human osteosarcoma Saos-2 cells. Histochem J. 1996 Jul;28(7):495-504. PubMed PMID: 8872139. (IF: 1,5)


3 : Marmiroli S, Zini N, Bavelloni A, Faenza I, Ognibene A, Maraldi NM. Transfected Saos-2 cells overexpressing phosphoinositidase C beta 1 isoformaccumulate it within the nucleus. Biol Cell. 1996;86(2-3):121-6. PubMed PMID:8893501.(IF: 3.488)


2 : Zini N, Ognibene A, Marmiroli S, Bavelloni A, Maltarello MC, Faenza I, Valmori A, Maraldi NM. The intranuclear amount of phospholipase C beta 1 decreases following cell differentiation in Friend cells, whereas gamma 1 isoformis not affected. Eur J Cell Biol. 1995 Sep;68(1):25-34. PubMed PMID: 8549587.(IF: 3.213)


1 : Falcieri E, Gobbi P, Cataldi A, Zamai L, Faenza I, Vitale M. Nuclear pores in the apoptotic cell. Histochem J. 1994 Sep;26(9):754-63. PubMed PMID: 7843986. (IF: 1,5)